| Document |
Document Title |
|
WO/2022/146096A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture medium, an extract of the culture medium, vesicles, and anti-inflammatory and/or antibacterial uses thereof. A novel strain and vesicles derived therefro...
|
|
WO/2022/143646A1 |
Provided are a recombinant strain for producing L-glutamic acid by modifying a gene BBD29_09525, and a construction method therefor and an application thereof. The recombinant strain is a bacterium that generates L-glutamic acid and has ...
|
|
WO/2022/146235A1 |
The present invention relates to a method for producing an enantiomerically pure or enantiomerically enriched (R)- mandelic acid or a derivative thereof using one or more recombinant microbial cells genetically engineered to overexpress ...
|
|
WO/2022/142969A1 |
A method for preparing xylitol by fermenting xylose secondary mother liquor, comprising the steps of performing fermentation treatment on mixed liquor of xylose secondary mother liquor and xylose concentrated liquor, and replacing subseq...
|
|
WO/2022/144796A1 |
A method executed by an engine of a computing device for simulating microalgae fermentation is described. The engine receives an input from a user. The input includes an identification of a microalgae, an identification of a culture medi...
|
|
WO/2022/145807A1 |
The present application relates to a Bifidobacterium animalis subsp. lactis HEM20-01 strain (KCTC14143BP), and a composition comprising the strain for treating, preventing, or alleviating depression. Bifidobacterium animalis subsp. lacti...
|
|
WO/2022/146137A1 |
The present invention relates to a compound, represented by formula (I): (I) wherein a) R, R1, R2 and R4 are independently of one another a hydrogen 0 atom or a C1-C6 linear or branched alkyl, or a C1-C6 linear or branched alkenyl, or a ...
|
|
WO/2022/143763A1 |
Disclosed are a strain having enhanced L-glutamic acid productivity, a construction method therefor, and an application thereof. Point mutation is introduced into a wild type BBD29-00405 gene in corynebacterium glutamicum, so that the 59...
|
|
WO/2022/143550A1 |
The present invention provides a mesothelin binding molecule, comprising an anti-mesothelin single domain antibody. Complementarity determining regions (CDR) of the single domain antibody comprise CDR1 shown in SEQ ID NO: 1, CDR2 shown i...
|
|
WO/2022/143596A1 |
Provided is a method for displaying a polypeptide of interest such as full-length IgG antibody on yeast host cells, wherein heavy chain and light chain of polypeptide are expressed in two cassettes. ER-targeting peptide and the secretion...
|
|
WO/2022/141934A1 |
Disclosed in the present invention are Staphylococcus aureus standard strains, which respectively have deposit numbers of GDMCC 60841, GDMCC 60843, GDMCC 60844 and GDMCC 60845, and can be used in different fields such as food, medicine a...
|
|
WO/2022/141944A1 |
The present invention provides three strains of Campylobacter jejuni, the preservation number of the strain 346-1C being GDMCC 60857, the preservation number of the strain 3853-1A being GDMCC 60858, and the preservation number of the str...
|
|
WO/2022/145901A1 |
The present invention relates to a composition for preventing or treating cancer comprising, as an active ingredient, nanovesicles derived from a Lactobacillus fermentum strain isolated from kimchi. The Lactobacillus fermentum strain-der...
|
|
WO/2022/145902A1 |
The present invention relates to a composition for the prevention or treatment of cancer, comprising, as an active ingredient, nanovesicles derived from a Lactobacillus sakei strain isolated from Kimchi. The nanovesicles derived from a L...
|
|
WO/2022/146718A1 |
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating diseases associated with hyperphenylalaninemia are disclosed.
|
|
WO/2022/147251A1 |
Disclosed herein are methods and compositions useful for the treatment of Autism Spectrum Disorder (ASD). The methods and compositions include combination therapy with probiotics and oxytocin (OXT), resulting in a therapeutic synergy tha...
|
|
WO/2022/143581A1 |
The present invention relates to the field of renewable energy sources in biotechnology, in particular to a method for producing citric acid by means of degrading coarse feed using a naturally symbiotic mixed culture. The mixed culture Y...
|
|
WO/2022/145600A1 |
The present invention relates to: Debaryomyces hansenii SMFM201812-3 strain having meat tenderizing and flavor-improving functions; Debaryomyces hansenii SMFM201905-5 strain; a meat tenderizing and flavor-improving composition and a meat...
|
|
WO/2022/141939A1 |
The present invention relates to the technical field of bioengineering, and in particular relates to three Vibrio parahaemolyticus standard strains which conform to domestic propagation laws and can be used as standard reference strains ...
|
|
WO/2022/144783A1 |
A method executed by a bioreactor system to cultivate a microalgae comprising a photoreceptor sensitive to a region of a visible spectrum under an autotrophic condition and a fermentation condition is described. A first process incubates...
|
|
WO/2022/143225A1 |
Provided are an engineered bacteria for producing pseudouridine and an application thereof. The engineered bacteria is obtained by means of gene-cloning pseudouridine synthetic genes pumH, pumJ and pumD from Streptomyces sp.ID38640 into ...
|
|
WO/2022/143113A1 |
Chromium-rich yeast, a preparation method therefor and an application thereof. The chromium-rich yeast has a chromium mass content of >38000 ppm, an organic chromium proportion of >97% by mass, and a chromium absorption rate of >50% by m...
|
|
WO/2022/141936A1 |
Disclosed are standard reference strains of staphylococcus argenteus with preservation numbers GDMCC 60854, GDMCC 60948 and GDMCC 60949, respectively, which can be used in different fields such as food, medicament, clinical tests and the...
|
|
WO/2022/141942A1 |
The present invention relates to the technical field of bioengineering, and in particular to five standard strains of Bacillus cereus which appear in China Autonomous Intellectual Property and conform to Domestic Propagation Law. In addi...
|
|
WO/2022/143761A1 |
Provided is a method for introducing a point mutation into a BBD29_04920 gene coding sequence in Corynebacterium or improving the expression thereof. According to the point mutation, the base at position 1560 of the BBD29_04920 gene sequ...
|
|
WO/2022/144483A1 |
Disclosed are a Lactobacillus plantarum strain, the probiotic use of same by means of a gastro-resistant capsule, and a bioactive product coated with an antimicrobial whey coating formulation obtained by fermenting whey using said strain...
|
|
WO/2022/143639A1 |
Disclosed in the present invention are a recombinant strain for producing L-glutamic acid by means of modifying gene BBD29_11265, and a construction method and the use thereof. The recombinant strain is a bacterium that generates L-gluta...
|
|
WO/2022/144613A1 |
A Cold Brew Tea Method of Producing Kombucha A cold brew tea method of producing kombucha. The method comprise a method of making a tea-based fermented drink, comprising steps of preparing the tea leaves picked from Camellia Sinesis plan...
|
|
WO/2022/143762A1 |
Provided are a recombinant strain of modifying gene BBD29_14900, and a construction method and the use thereof. The specific use thereof is for producing L-glutamic acid. Further provided is a method for introducing point mutation into a...
|
|
WO/2022/134658A1 |
Provided is a Bifidobacterium breve strain capable of preventing and alleviating psoriasis, and an application thereof, belonging to the technical field of micro-organisms and the technical field of medicines. Provided are new uses of Bi...
|
|
WO/2022/139502A1 |
The present invention relates to: a (Saccharomyces cerevisiae) strain deposited with accession number KCTC 14268BP; a cosmetic composition, a quasi-drug composition, or a food composition, each comprising at least one selected from the g...
|
|
WO/2022/137148A1 |
This invention relates to use of a strain of lactic acid bacteria for inhibiting the growth of methane-producing bacteria and/or archaea in the gastrointestinal tract of monogastric animals, reducing the ability of the microbiome of the ...
|
|
WO/2022/135173A1 |
Provided is an Escherichia coli strain, H03A2190830. The deposit number thereof is CCTCC NO: M2019900. Further provided are a method for producing a polysialic acid by means of using the Escherichia coli, and a method for producing a sia...
|
|
WO/2022/135139A1 |
Provided is a nucleic acid construct for AIDS gene therapy. The nucleic acid construct comprises multiple polynucleotides encoding single chain variable region fragments of an anti-AIDS neutralizing antibody, and polynucleotides encoding...
|
|
WO/2022/134628A1 |
Disclosed is a method for regulating and controlling the binding power of deposited calcite induced by microorganisms. The present invention falls within the field of substrate performance regulation and control. The method comprises the...
|
|
WO/2022/139548A1 |
The present invention relates to a novel microorganism having plastic decomposition activity and, more specifically, to Acinetobacter nosocomialis having the activity of decomposing plastics and separated from soil in which waste plastic...
|
|
WO/2022/135425A1 |
Provided are an attenuated virus of a flavivirus virus and the use thereof. The attenuated virus comprises a polyadenylic acid (poly(A)) sequence, wherein the polyadenylic acid (poly(A)) is used for replacing a part of the nucleotide seq...
|
|
WO/2022/137149A1 |
This invention relates to use of a strain of lactic acid bacteria for inhibiting the growth of methane-producing bacteria and/or archaea in the forestomach of ruminant animals, reducing the ability of the rumen microbiome to produce meth...
|
|
WO/2022/134564A1 |
Provided is a method for producing jasmonic acid by using microbial solid state fermentation, belonging to the technical field of biotechnology. By inoculating Lasiodiplodia sp. into a solid state fermentation medium containing wheat ker...
|
|
WO/2022/133917A1 |
A modified Phosphoenolpyruvate carboxylase. Compared to an amino acid sequence of a wild-type Phosphoenolpyruvate carboxylase, amino acids at bit 771 and/or bit 931 and/or bit 943 of an amino acid sequence of the modified Phosphoenolpyru...
|
|
WO/2022/140538A1 |
Modified bacterium capable of degrading oxalate, mutant proteins that facilitate oxalate degradation, and methods for their use are disclosed.
|
|
WO/2022/135266A1 |
Provided are an enzyme system for degrading plant polysaccharides and an application thereof in degradation of corn bran. Genetic modification is performed on a transcription factor for regulating and controlling the expression of a plan...
|
|
WO/2022/134236A1 |
The present invention relates to an alkaline protease mutant, a gene thereof, an engineering bacteria thereof, a preparation method therefor and the use thereof, which belong to the technical field of bioengineering. The preparation meth...
|
|
WO/2022/134710A1 |
A strain of Lactobacillus fermentum CCFM1139 and an application thereof are provided. The Lactobacillus fermentum has a preservation number of GDMCC No: 61116, and has the effect of relieving periodontitis. Same can inhibit the formation...
|
|
WO/2022/133229A1 |
The technology relates in part to a strain of Bacillus pumilus bacteria deposited under ATCC accession number PTA-126909 and compositions derived from the bacteria for a variety of uses, including cosmetic and commercial compositions. Th...
|
|
WO/2022/131623A1 |
The present invention relates to a Candida utilis strain with high tripeptide productivity and/or alcohol dehydrogenase activity and use thereof.
|
|
WO/2022/128492A1 |
The invention relates to a method for producing alcohols, according to which a sugary fluid (2) is introduced into a reaction section (1) comprising a support (4) on which microorganisms are immobilised, in order to produce, by fermentat...
|
|
WO/2022/127848A1 |
Lactobacillus reuteri CCFM1132 for alleviating hyperuricemia and ulcerative colitis, and an application, relating to the technical field of microorganisms. The Lactobacillus reuteri CCFM1132 is capable of lowering the serum uric acid lev...
|
|
WO/2022/133261A1 |
The present disclosure generally relates to the production of natural vanillin by bioconversion using isoeugenol as the substrate. More specifically, the present methods utilize a fungal isoeugenol monooxygenase encoded by VplEM gene fro...
|
|
WO/2022/127039A1 |
Disclosed are riboflavin-producing bacillus subtilis, and a construction method therefor and the use thereof. The bacillus subtilis is a bacillus subtilis strain with at least one gene locus mutated in purR, ribC or pyrE. The bacillus su...
|
